Diabetes is a cardiovascular and metabolic illness marked by inflammation. It increases almost every cardiovascular risk factor, and the vast majority of diabetics die from heart disease. Recent clinical research discoveries, together with patient education, offer new avenues for improving cardiovascular outcomes in diabetes patients. Diabetes and cardiovascular disease (CVD) have a complex aetiology. Understanding these complicated disease pathways can help clinicians recognise and treat CVD in diabetes patients, as well as help patients avoid potentially deadly effects.
Diabetic cardiomyopathy refers to cardiovascular disorders that occur in diabetic people and are not caused by another recognised CVD, such as hypertension or coronary artery disease. Diabetes patients are predisposed to heart failure even early in the course of their disease due to morphological and functional abnormalities in diabetic cardiomyopathy.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
